Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial.
Biannual rituximab infusions over 18 months effectively maintain remission after a "standard" remission induction regimen for patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV). ⋯ French Ministry of Health and Hoffmann-La Roche.
-
Multicenter Study
Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey.
The evolving outbreak of coronavirus disease 2019 (COVID-19) is requiring social distancing and other measures to protect public health. However, messaging has been inconsistent and unclear. ⋯ National Institutes of Health.
-
Multicenter Study
Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic.
The coronavirus disease 2019 (COVID-19) pandemic challenges hospital leaders to make time-sensitive, critical decisions about clinical operations and resource allocations. ⋯ University of Pennsylvania Health System and the Palliative and Advanced Illness Research Center.
-
Multicenter Study
The Unrecognized Prevalence of Primary Aldosteronism.
Primary aldosteronism is a nonsuppressible renin-independent aldosterone production that causes hypertension and cardiovascular disease. ⋯ National Institutes of Health.
-
Randomized Controlled Trial Multicenter Study
Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial.